| |
| |
|
| Insider
Information: |
Cumming John W |
| Relationship: |
|
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13,821 |
|
|
Indirect Shares
|
8,120 |
|
|
| Direct
Value |
$641,405 |
|
|
|
Indirect Value
|
$607,214 |
|
|
| Total
Shares |
21,941 |
|
|
| Total
Value |
$1,248,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hologic Inc |
HOLX |
President and CEO |
2013-11-14 |
8,565 |
2013-11-14 |
8,120 |
Premium* |
|
|
T2 Biosystems, Inc. |
TTOO |
|
2023-09-15 |
5,256 |
2018-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2005-03-03 |
4 |
OE |
$7.69 |
$384,375 |
D/D |
50,000 |
52,250 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2008-08-07 |
4 |
B |
$20.00 |
$1,000,567 |
D/D |
50,000 |
301,654 |
2.81 |
- |
|
| HOLX |
Hologic Inc |
Chairman |
• • – |
2011-03-03 |
4 |
S |
$21.25 |
$1,062,500 |
D/D |
(50,000) |
388,524 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman |
• • – |
2011-01-14 |
4 |
D |
$19.17 |
$1,202,802 |
D/D |
(62,744) |
438,524 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman and CEO |
• • – |
2005-02-28 |
4 |
OE |
$5.00 |
$364,000 |
D/D |
65,000 |
71,320 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman and CEO |
• • – |
2005-02-28 |
4 |
S |
$37.26 |
$2,421,900 |
D/D |
(65,000) |
6,320 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman |
• • – |
2011-03-08 |
4 |
S |
$21.37 |
$1,505,495 |
D/D |
(70,449) |
305,975 |
0 |
- |
|
| HOLX |
Hologic Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2008-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
125,827 |
0 |
- |
|
| TTOO |
T2 Biosystems, Inc. |
Director |
– • – |
2022-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
81,967 |
132,819 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2005-03-01 |
4 |
OE |
$5.05 |
$474,675 |
D/D |
82,250 |
88,570 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman and CEO |
• • – |
2005-02-25 |
4 |
S |
$38.41 |
$3,264,850 |
D/D |
(85,000) |
6,320 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman and CEO |
• • – |
2005-02-25 |
4 |
OE |
$5.00 |
$443,750 |
D/D |
85,000 |
91,320 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2005-03-01 |
4 |
S |
$37.17 |
$3,208,637 |
D/D |
(86,320) |
2,250 |
|
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2007-02-06 |
4 |
S |
$55.46 |
$5,407,496 |
D/D |
(97,500) |
9,676 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2007-02-06 |
4 |
OE |
$9.50 |
$926,250 |
D/D |
97,500 |
107,176 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2007-02-02 |
4 |
OE |
$4.75 |
$593,750 |
D/D |
125,000 |
134,676 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2007-02-02 |
4 |
S |
$55.72 |
$6,964,750 |
D/D |
(125,000) |
9,676 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2008-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
231,000 |
532,654 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2007-02-05 |
4 |
OE |
$2.89 |
$2,022,625 |
D/D |
342,500 |
352,176 |
0 |
- |
|
| HOLX |
Hologic Inc |
Chairman & CEO |
• • – |
2007-02-05 |
4 |
S |
$55.40 |
$18,975,425 |
D/D |
(342,500) |
9,676 |
0 |
- |
|
70 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
